School of Medicine
Showing 9,961-9,980 of 13,049 Results
-
Serena Sanulli
Assistant Professor of Genetics
Current Research and Scholarly InterestsWe study the organizing principles of the genome and how these principles regulate cell identity and developmental switches. We combine Biochemistry and Biophysical methods such as NMR and Hydrogen-Deuterium Exchange-MS with Cell Biology, and Genetics to explore genome organization across length and time scales and understand how cells leverage the diverse biophysical properties of chromatin to regulate genome function.
-
Mrinmoy Sanyal
Casual - Non-Exempt, Radiation Oncology - Radiation Therapy
BioMrinmoy Sanyal obtained his undergraduate and master's degree in Human Physiology at the University of Calcutta. He did his Ph.D. in Biochemistry at All India Institute of Medical Sciences, New Delhi, working on reproductive immunology, with the focus on trophoblast invasion and differentiation and their role in human blastocyst implantation. Then, he moved to Stanford University for a postdoctoral fellowship on the role of transcription factor Pbx1, a leukemia proto-oncogene, on B cell development. Currently, he is Research Scientist at Department of Biochemistry, Stanford University. His work covers various topics, including B cell responses to viral infection and vaccination, human primary immunodeficiency, and biology of lymphocyte development and function and to elucidate etiology of immunological disorders.
-
Robert Sapolsky
John A. and Cynthia Fry Gunn Professor, Professor of Biology, of Neurology and Neurological Sciences and of Neurosurgery
Current Research and Scholarly InterestsNeuron death, stress, gene therapy
-
Kavita Sarin, MD, PhD
Professor of Dermatology
Current Research and Scholarly InterestsMy research encompasses two main areas: 1) Using next-generation RNA, whole genome, and exome sequencing, we are investigating the genetic alterations involved in skin cancer progression, response to therapy, and other clinical outcomes and 2) We are developing and implementing genome-wide genetic risk prediction assessments for skin cancer into clinical use and studying the impact of this information on patient care.
